Shares of Zydus Lifesciences Ltd ended at ₹889.00, down by ₹10.90, or 1.21%, on the BSE.
Source link
Zydus Lifesciences' venture arm invests in Illexcor Therapeutics for sickle cell disease therapies
Shares of Zydus Lifesciences Ltd ended at ₹889.00, down by ₹10.90, or 1.21%, on the BSE.
Source link